{"slideshow_credits": null, "snippet": "Excluding a drug that\u2019s no better, and twice as expensive, isn\u2019t rationing \u2014 it\u2019s rational.", "abstract": "Op-Ed article by Peter B Bach, Leonard B Saltz and Robert E Wittes, doctors at Memorial Sloan-Kettering Cancer Center, explains the hospital's decision not to use new cancer drug Zaltrap, which has proved to be no more effective but is more than twice as expensive; contends that this is one example of how the medical community needs to consider financial costs of treatments for patients alongside their benefits.", "section_name": "Opinion", "print_page": "25", "document_type": "article", "byline": {"person": [{"firstname": "Peter", "role": "reported", "rank": 1, "organization": ""}], "original": "By PETER B. BACH, LEONARD B. SALTZ and ROBERT E. WITTES", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/10/15/opinion/a-hospital-says-no-to-an-11000-a-month-cancer-drug.html", "lead_paragraph": "Excluding a drug that\u2019s no better, and twice as expensive, isn\u2019t rationing \u2014 it\u2019s rational.", "headline": {"seo": "A Hospital Says \u2018No\u2019 to an $11,000-a-Month Cancer Drug", "main": "In Cancer Care, Cost Matters", "print_headline": "In Cancer Care, Cost Matters", "content_kicker": "Op-Ed Contributor", "kicker": "Op-Ed Contributor"}, "_id": "5087268f95e998af71187cb1", "word_count": "905", "multimedia": [], "pub_date": "2012-10-15T00:00:00Z", "source": "The New York Times", "news_desk": "OpEd", "keywords": [{"value": "Health Insurance and Managed Care", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Cancer", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Memorial Sloan-Kettering Cancer Center", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Patient Protection and Affordable Care Act (2010)", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Avastin (Drug)", "name": "subject", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "Op-Ed"}